USP33 and lung cancer: To test if the deubiquitinating activity of USP33 plays a role in mediating Slit activity in lung cancer cells, we used a construct of USP33 mutant that contained a point mutation, C163A, in the catalytic domain of USP33 and was capable of acting in a dominant negative fashion (Yuasa-Kawada et al., 2009b).